AnalysisNews

MMED today

$18.25+$0.89 (+5.13%)close Nov 11, 2026

Trend

DailyDowntrend (starting)

4 hourExpanding

1 hourStrong Bullish

15 minStrong Bullish

5 minStrong Bearish

Daily trend turns up above $24.43

Key levels

Resistance$24.43

Resistance$19.93

Support$18.04

Support$16.55

Latest news & SEC filings

NewsMiniMed picks Dr. David Segal for top medical post

AnalystJefferies starts Minimed Group coverage with Hold rating, $22 price target

All MMED news →

About MiniMed

MiniMed makes and sells devices and software for managing diabetes, including insulin pumps, glucose sensors, smart insulin pens, and companion apps. Its products are built around automated insulin delivery and connected injection systems for patients needing frequent insulin. The company serves doctors, diabetes specialists, and patients, and it operates globally with manufacturing sites in California and Puerto Rico.

Based on the company's 10-K filed Jun 29, 2026.

NASDAQ · Healthcare

MiniMed Group, Inc. Common Stock (MMED)

$18.25+0.89 (+5.13%)
WATCHLISTGrade: BRisk: LOW
1D5D1M1Y5YMaxSign up for all timeframes
17.4018.0918.7819.4718.25Oct 9Oct 19Oct 27Nov 4
High18.66
Low17.25
Open17.46
Volume5.26M
Avg Vol12.58M
VWAP18.21
30d High20.16
30d Low16.71
30d Chg-6.89%

What Is the Price Target for MMED?

SEPT Low Target

$16.00

SEPT Mid Target

$26.00

SEPT High Target

$29.00

Analyst Consensus

$26.00

Current: $18.25Upside: +42.5%Confidence: 85%Method: Analyst Consensus

Is MMED a Buy or Sell Right Now?

63
Investability Score
WATCHLIST12-18 months

Thesis

  • •Revenue growing 10.0% YoY with STABLE trend — consistent growth.

AI-Powered Trading Signals

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for MMED.

Start Free Trial →

Is MMED Overvalued or Undervalued?

Valuation Verdict

FAIR

Methods Used

P/E Forward, Analyst Consensus

Fair Value

$22.62

37

Moat Score

NONE

4/9

Piotroski Score

4.2

Altman Z-Score

What Is Smart Money Doing with MMED?

Insider Signal

NEUTRAL

0 buys / 0 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

N/A

Short Squeeze Risk

LOW

Signal: NEUTRAL

Recent Insider Activity

NameTitleTypeSharesValueDate
Dianaty AliofficerSale449$8KOct 28, 2026
Bricker AmydirectorBuy11,877-Oct 15, 2026
Hopkins Robert (Bob)directorBuy11,877-Oct 15, 2026
Medtronic plc10% ownerSale252,813,348-Oct 15, 2026
Endicott David J.directorBuy3,374-Oct 15, 2026
Denton Sheila A.officerBuy58,939-Oct 1, 2026

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See All Smart Money Signals →

MMED Growth Story

Revenue YoY

10.0%

3yr Revenue CAGR

N/A%

EPS Growth YoY

-122.5%

FCF Growth YoY

50.5%

Revenue Trend

STABLE

Dark Pool Trades for MMED

PREVIEW

SEPT Investing tracks real-time dark pool institutional trades for MMED, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.

TimePriceSizeValueSide
21:00:35$18.251,828$$33KBUY
21:00:29$18.252,505$$46KBUY
21:00:28$18.252,300$$42KBUY
21:00:02$18.253,200$$58KBUY
21:00:01$18.251,000$$18KBUY

5 dark pool trades shown · $$198K preview volume

Real-time institutional flow, block trades, and net positioning

See all dark pool activity

Options Flow for MMED

PREVIEW

SEPT Investing provides real-time options flow tracking for MMED, including unusual sweep detection, block trades, and dealer positioning. Each trade shows strike, expiry, premium, implied volatility, and greek values for informed decision-making.

TypeStrikeExpiryDTEPremiumSizeTrade
PUT$17.5Nov 209$$2505SWEEP
PUT$17.5Nov 209$$55011SWEEP
PUT$17.5Nov 209$$375075SWEEP
PUT$17.5Nov 209$$1002SWEEP
PUT$17.5Nov 209$$1503SWEEP

5 options trades shown · 0% calls

Unusual activity, GEX levels, max pain, and dealer positioning

See full options flow

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for MiniMed Group, Inc. Common Stock (MMED) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...

AI-Powered Trading Signals.

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

Try SEPT Free for 7 Days →

MMED — frequently asked questions

What is MMED stock price today?

MiniMed Group, Inc. Common Stock (MMED) is at $18.25, up 5.13% (+$0.89) at the Nov 11, 2026 close.

Why is MMED stock moving today?

Latest MMED news — Nov 3, 2026: MiniMed picks Dr. David Segal for top medical post · Oct 12, 2026: Jefferies starts Minimed Group coverage with Hold rating, $22 price target

What is the MMED price target?

The average analyst price target for MMED is $26.00, ranging from $16 to $29, based on 13 analysts. Latest: Jefferies initiates on Oct 12, 2026.

What do analysts rate MMED?

Analyst ratings for MMED: 1 Buy, 15 Hold, 0 Sell — consensus Hold.

Did MMED beat earnings?

MMED last reported on Sep 1, 2026: EPS $0.12 vs $0.12 expected — a miss of 3.3%.

Does MMED pay a dividend?

MMED does not currently pay a dividend.

How much debt does MMED have?

MiniMed Group, Inc. Common Stock reported $11M of debt and $11M of cash (Apr 30, 2025).

What are MMED support and resistance levels?

Support: $18.04, $16.55, $14.70. Resistance: $19.93, $24.43.

What are insiders doing with MMED?

Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.

What is the latest news on MMED?

Nov 3, 2026: MiniMed picks Dr. David Segal for top medical post · Oct 12, 2026: Jefferies starts Minimed Group coverage with Hold rating, $22 price target